CareLit Fachartikel
Novel harnessing of innate and adaptive anti-cancer immunity: NLRP3-inflammasome activation facilitates immune checkpoint blockade in the treatment of mesenchymal stage IV colorec…
L Klimpe, E Neuwirt, C Enderle, L Schäfer, L Marx, S Fichtner-Feigl, O Groß, R Kesselring, C Berlin · Zeitschrift für Gastroenterologie · 2025 · Heft 08 · S. e523
Dokument
953927
CareLit-ID
Jahr
2025
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig
Bibliografische Angaben
Zusammenfassung
Novel harnessing of innate and adaptive anti-cancer immunity: NLRP3-inflammasome activation facilitates immune checkpoint blockade in the treatment of mesenchymal stage IV colorectal cancer
Schlagworte
Novel
Harnessing
Innate
Adaptive
Anti-Cancer
Immunity
Nlrp3-Inflammasome
Activation
Facilitates
Immune
Checkpoint
Blockade
Zeitschrift für Gastroenterologie